2026 Lucidquest

• The June 12, 2026, public health update reports on a current outbreak of the Bundibugyo virus disease and the introduction of new clinical guidelines for CKM syndrome. • The report covers critical developments across infectious disease surveillance, prevention strategies, chronic disease management, and emerging medical technologies. • These updates are vital for healthcare providers and policymakers to implement the latest clinical standards and contain the viral spread.

• Public Health Today's June 5, 2026 update reports on a current Ebola outbreak in the Democratic Republic of the Congo and the release of Phase 3 clinical data for the pancreatic cancer drug daraxonrasib. • Researchers at McMaster University have isolated a new compound from *Streptomyces rimosus* designed to combat antibiotic-resistant bacteria. • A new vector-control approach is being developed to suppress disease-carrying mosquito populations without using conventional insecticides, addressing the growing threat of insecticide resistance.

• WHO advisory groups have selected several candidates for clinical trial evaluation during the current outbreak response, including remdesivir, Maftivimab®, and vaccine candidates rVSV and ChAdOx1 Bundibugyo. • New research highlights durable results from PCSK9 base-editing (VERVE-102) and examines the impact of GLP-1 agonists like semaglutide on health outcomes. • Experts clarified that Deet remains effective for real-world use, noting that certain conditioning effects were limited to laboratory settings and may not reflect typical application patterns.